# Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers

> **NCT02666833** · — · UNKNOWN · sponsor: **Massachusetts General Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Carcinoma, Basal Cell
- Carcinoma, Squamous Cell

## Interventions

- **DEVICE:** Polarization Enhanced Reflectance and Fluorescence System

## Key facts

- **NCT ID:** NCT02666833
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2017-07
- **Final completion:** 2017-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02666833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02666833, "Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02666833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*